The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Penndorf, Nathalie Denise
    Company Director born in August 1971
    Individual (1 offspring)
    Officer
    2024-02-06 ~ now
    OF - director → CIF 0
  • 2
    Raffensperger, Alan Henry
    Ceo born in November 1960
    Individual (1 offspring)
    Officer
    2018-10-17 ~ now
    OF - director → CIF 0
  • 3
    Scarle, Gary John
    Vp, Operations born in March 1967
    Individual (1 offspring)
    Officer
    2018-10-17 ~ now
    OF - director → CIF 0
  • 4
    Mr Adam Todd Feinstein
    Born in March 1972
    Individual (1 offspring)
    Person with significant control
    2024-01-12 ~ now
    PE - Has significant influence or control → CIF 0
  • 5
    5th Floor, 2 Copthall Avenue, London, England
    Corporate (3 parents, 70 offsprings)
    Equity (Company account)
    2 GBP2023-12-31
    Officer
    2019-10-25 ~ now
    OF - secretary → CIF 0
Ceased 11
  • 1
    Huss, Ann-marie
    Company Director born in April 1987
    Individual
    Officer
    2011-08-10 ~ 2016-08-15
    OF - director → CIF 0
  • 2
    Broadis, Jeremy Thomas James
    Chief Business Officer born in January 1969
    Individual
    Officer
    2021-02-10 ~ 2024-02-23
    OF - director → CIF 0
  • 3
    Corbett, Mark Edward
    Executive Vice President born in July 1972
    Individual (8 offsprings)
    Officer
    2018-06-04 ~ 2021-01-19
    OF - director → CIF 0
  • 4
    Mr Mans Petter Krantz
    Born in March 1961
    Individual
    Person with significant control
    2016-04-06 ~ 2024-01-12
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 5
    Munro, Wendey Heather
    Individual
    Officer
    2017-06-28 ~ 2018-10-01
    OF - secretary → CIF 0
  • 6
    Reichart, Peter
    Born in May 1980
    Individual
    Officer
    2016-07-19 ~ 2018-10-17
    OF - director → CIF 0
  • 7
    Goetsch, Miki Kathleen
    Company Director born in August 1992
    Individual
    Officer
    2016-07-19 ~ 2018-10-17
    OF - director → CIF 0
  • 8
    Pousse, Muriel Denise
    Born in December 1972
    Individual
    Officer
    2011-08-10 ~ 2011-08-17
    OF - director → CIF 0
  • 9
    Brosz, Krzysztof Marian
    Head Of Finance born in September 1980
    Individual
    Officer
    2018-10-17 ~ 2021-02-09
    OF - director → CIF 0
  • 10
    1, Lumley Street, Mayfair, London, United Kingdom
    Dissolved corporate (2 parents, 4 offsprings)
    Equity (Company account)
    8 GBP2019-06-30
    Officer
    2017-05-04 ~ 2018-10-17
    PE - director → CIF 0
  • 11
    JD CORPORATE SERVICES LIMITED - 1991-03-04
    1, Lumley Street, Mayfair, London, United Kingdom
    Dissolved corporate (3 parents, 84 offsprings)
    Equity (Company account)
    2 GBP2019-04-30
    Officer
    2011-08-10 ~ 2019-10-25
    PE - secretary → CIF 0
parent relation
Company in focus

INCEPTUA LIMITED

Previous name
MULTIPHARMA CLINICAL SUPPLIES LIMITED - 2017-03-07
Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Cost of Sales
-42,107,304 GBP2023-01-01 ~ 2023-12-31
-26,813,641 GBP2022-01-01 ~ 2022-12-31
Administrative Expenses
-5,979,057 GBP2023-01-01 ~ 2023-12-31
-6,328,887 GBP2022-01-01 ~ 2022-12-31
Other Interest Receivable/Similar Income (Finance Income)
56 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Interest Payable/Similar Charges (Finance Costs)
-74,064 GBP2023-01-01 ~ 2023-12-31
-29,746 GBP2022-01-01 ~ 2022-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-201,819 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
Retained earnings (accumulated losses)
3,078,966 GBP2023-01-01 ~ 2023-12-31
-241,152 GBP2022-01-01 ~ 2022-12-31
Trade Debtors/Trade Receivables
Current
12,986,997 GBP2023-12-31
9,239,814 GBP2022-12-31
Cash and Cash Equivalents
3,340,101 GBP2023-12-31
2,143,478 GBP2022-12-31
Corporation Tax Payable
Current
201,819 GBP2023-12-31
0 GBP2022-12-31
Creditors
Non-current
-268,517 GBP2023-12-31
-359,098 GBP2022-12-31
Equity
Called up share capital
100,000 GBP2023-12-31
100,000 GBP2022-12-31
Retained earnings (accumulated losses)
190,323 GBP2023-12-31
-2,888,643 GBP2022-12-31
Equity
290,323 GBP2023-12-31
-2,788,643 GBP2022-12-31
-2,647,491 GBP2021-12-31
Average Number of Employees
252023-01-01 ~ 2023-12-31
232022-01-01 ~ 2022-12-31
Wages/Salaries
2,346,393 GBP2023-01-01 ~ 2023-12-31
2,276,147 GBP2022-01-01 ~ 2022-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
89,112 GBP2023-01-01 ~ 2023-12-31
85,210 GBP2022-01-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
2,697,682 GBP2023-01-01 ~ 2023-12-31
2,710,640 GBP2022-01-01 ~ 2022-12-31
Director Remuneration
466,753 GBP2023-01-01 ~ 2023-12-31
444,705 GBP2022-01-01 ~ 2022-12-31
Profit/Loss on Ordinary Activities Before Tax
3,280,785 GBP2023-01-01 ~ 2023-12-31
-241,152 GBP2022-01-01 ~ 2022-12-31
Tax Expense/Credit at Applicable Tax Rate
770,984 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
424,888 GBP2023-12-31
424,888 GBP2022-12-31
Furniture and fittings
366,274 GBP2023-12-31
348,446 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
791,162 GBP2023-12-31
773,334 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
135,192 GBP2023-12-31
57,939 GBP2022-12-31
Furniture and fittings
325,052 GBP2023-12-31
309,814 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
460,244 GBP2023-12-31
367,753 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
77,253 GBP2023-01-01 ~ 2023-12-31
Furniture and fittings
15,238 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
92,491 GBP2023-01-01 ~ 2023-12-31
Prepayments
Current
7,356,327 GBP2023-12-31
3,831,884 GBP2022-12-31
Trade Creditors/Trade Payables
Current
11,510,935 GBP2023-12-31
11,417,626 GBP2022-12-31
Accrued Liabilities
Current
4,304,747 GBP2023-12-31
2,956,776 GBP2022-12-31
  • INCEPTUA LIMITED
    Info
    MULTIPHARMA CLINICAL SUPPLIES LIMITED - 2017-03-07
    Registered number 07735749
    Vista, 2 William Street, Windsor, Berkshire SL4 1BA
    Private Limited Company incorporated on 2011-08-10 (13 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2024-05-03
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.